Lisa Y. Foo - 24 Feb 2026 Form 4 Insider Report for TENET HEALTHCARE CORP (THC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 Feb 2026, 20:00:05 UTC
Prior SEC filing
17 Feb 2026
Next SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Chad J. Wiener, as Attorney-in-fact for Lisa Y. Foo

Key filing fact

Lisa Y. Foo filed Form 4 for TENET HEALTHCARE CORP (THC) on 26 Feb 2026.

Key facts

  • This page summarizes Lisa Y. Foo's Form 4 filing for TENET HEALTHCARE CORP (THC).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 26 Feb 2026, 20:00.

Change

  • Previous filing in this sequence was filed on 17 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001916153 Primary reporting owner

Foo Lisa Y

Relationship
EVP, Chief Operating Officer
Address
14201 DALLAS PARKWAY, DALLAS
Signature
Chad J. Wiener, as Attorney-in-fact for Lisa Y. Foo
Signature date
26 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

THC transaction

Common Stock

Options Exercise

Transaction value
Shares
+3,800
Change %
+7.7%
Price
Shares after
53,017
Date
24 Feb 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

THC transaction Derivative

2025 Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-3,800
Change %
-33%
Price
$0.000000
Shares after
7,602
Date
24 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,800
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026.

Footnote F3

Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .